论文部分内容阅读
目的:比较参麦注射液与常规西药治疗慢性心力衰竭的临床疗效。方法:将本组83例心力衰竭患者随机分为治疗组和对照组,对照组常规西医治疗,包括低盐饮食、限水。药物治疗使用血管紧张素转换酶抑制剂、β-受体阻滞剂、洋地黄制剂、利尿剂、硝酸酯制剂等,治疗组在对照组治疗的基础上加用参麦注射液40～60ml加入5%葡萄糖注射液250ml静滴,每天1次。14天为1疗程。结果:治疗组慢性心力衰竭患者应用参麦注射液后有效率为93.02%,对照组有效率为77.50%,治疗组总有效率明显优于对照组,有统计学意义(P<005),而治疗组的心功能改善也明显优于对照组,改善有显著性(P<005)。结论:参麦注射液可明显改善心力衰竭患者的临床症状和心功能,辅助治疗慢性心力衰竭疗效显著。
Objective: To compare the clinical efficacy of Shenmai injection and conventional western medicine in treating chronic heart failure. Methods: 83 patients with heart failure in this group were randomly divided into treatment group and control group. The control group received routine Western medical treatment including low-salt diet and water restriction. Drug treatment with angiotensin converting enzyme inhibitors, β-blockers, digitalis preparations, diuretics, nitrate preparations, the treatment group in the control group based on the treatment with Shenmai injection 40 ~ 60ml added 5% glucose injection 250ml intravenous infusion, 1 day. 14 days for a course of treatment. Results: The effective rate of the treatment group was 93.02%, the effective rate of the control group was 77.50%, the total effective rate of the treatment group was significantly better than that of the control group (P <005), while The improvement of cardiac function in the treatment group was also significantly better than the control group, with significant improvement (P <005). Conclusion: Shenmai injection can significantly improve the clinical symptoms and cardiac function in patients with heart failure, and the curative effect of adjuvant treatment of chronic heart failure is significant.